Methods of treating autism
AssigneeSeaside Therapeutics, Inc.
InventorsKathryn Roberts, Randall L. Carpenter, Mark F. Bear
Life of this patent
Estimating the term…
Abstract
Subjects having autism are treated with a composition that includes gamma-aminobutyric acid agonists. The gamma-aminobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen.
Claims26
A method of improving a social domain in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount of at least one gamma-aminobutyric acid agonist.
A method of decreasing at least one member selected from the group consisting of irritability and aggression in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount at least one gamma-aminobutyric acid agonist.
A method of improving a social domain in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount of at least about 99 mole percent R-baclofen in the composition.
A method of improving a communication domain in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount of at least about 99 mole percent R-baclofen in the composition.
Dependencies are inferred from the claim text.